Total Liabilities: The total value of all possible claims against the corporation.
MIRA Pharmaceuticals, Inc. (MIRA) had Total Liabilities of $0.70M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.98M |
|
-- |
|
-- |
|
$5.82M |
|
$-5.82M |
|
$-0.16M |
|
$-5.98M |
|
$-5.77M |
|
$-5.98M |
|
$-5.98M |
|
$-5.98M |
|
$-5.77M |
|
$-5.82M |
|
$-5.82M |
|
23.69M |
|
23.69M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$11.06M |
|
-- |
|
$0.04M |
|
$11.09M |
|
$0.70M |
|
-- |
|
-- |
|
|
Total Liabilities |
$0.70M |
$10.39M |
|
$10.39M |
|
$10.39M |
|
41.94M |
|
| Cash Flow Statement Financials | |
$-4.66M |
|
-- |
|
$8.18M |
|
$2.83M |
|
$6.35M |
|
$3.51M |
|
$6.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-57.58% |
|
-57.58% |
|
-53.93% |
|
-57.58% |
|
$0.25 |
|
$-0.20 |
|
$-0.20 |
|